Clinical Trial Product Stocks List

Recent Signals

Date Stock Signal Type
2021-04-14 BIIB 200 DMA Resistance Bearish
2021-04-14 BIIB 180 Bearish Setup Bearish Swing Setup
2021-04-14 HALO Crossed Above 50 DMA Bullish
2021-04-14 HALO Stochastic Reached Overbought Strength
2021-04-14 HALO Expansion Pivot Buy Setup Bullish Swing Setup
2021-04-14 HALO Pocket Pivot Bullish Swing Setup
2021-04-14 HCM NR7 Range Contraction
2021-04-14 HCM Upper Bollinger Band Walk Strength
2021-04-14 HCM Bollinger Band Squeeze Range Contraction
2021-04-14 HCM Bearish Engulfing Bearish
2021-04-14 HCM NR7-2 Range Contraction
2021-04-14 HCM Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-14 IMGN Slingshot Bearish Bearish Swing Setup
2021-04-14 IMGN Lower Bollinger Band Walk Weakness
2021-04-14 INCY Crossed Above 20 DMA Bullish
2021-04-14 INCY Crossed Above 50 DMA Bullish
2021-04-14 LBPH Lower Bollinger Band Walk Weakness
2021-04-14 LGND 20 DMA Resistance Bearish
2021-04-14 SUPN Upper Bollinger Band Walk Strength
2021-04-14 SUPN Stochastic Reached Overbought Strength
2021-04-14 SUPN Calm After Storm Range Contraction
2021-04-14 SUPN Doji - Bearish? Reversal
2021-04-14 SUPN New 52 Week High Strength
2021-04-14 SUPN New 52 Week Closing High Bullish

Recent News for Clinical Trial Product Stocks

Date Stock Title
Apr 14 BIIB Biogen to Present Trial Design of Aducanumab EMBARK Re-Dosing Study in Poster Session at 2021 Virtual AAN Annual Meeting on April 17-22, 2021
Apr 14 LBPH 22 Stocks Moving in Wednesday's Pre-Market Session
Apr 13 BIIB Sage (SAGE), Biogen Report Positive Data on Essential Tremor Study
Apr 13 SUPN Supernus approaches LOE for Trokendi, but Jefferies sees ‘a new product cycle’
Apr 13 SUPN IRhythm extends losses as more downgrades pile up, Aphria cut to neutral after earnings miss; and more in today’s analyst action
Apr 13 INCY Incyte to Report First Quarter Financial Results
Apr 12 BIIB Neurology Drug Study Does Little for Sage Therapeutics, or Its Partner Biogen
Apr 12 INCY Incyte Corporation (INCY) Presents at AACR Virtual Meeting 2021 - Slideshow
Apr 12 BIIB Biogen and Sage trade lower despite positive essential tremor trial
Apr 12 BIIB Sage-Biogen Essential Tremor Candidate Hits Primary Endpoint Goal, But 38% Of People Drop Out
Apr 12 BIIB Sage Stock Trips As Analysts Question Longevity Of Biogen-Partnered Drug
Apr 12 BIIB Sage Therapeutics/Biogen's SAGE-324 meets primary endpoint in essential tremor study
Apr 12 BIIB Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
Apr 10 IMGN ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting
Apr 9 BIIB Biogen Announces Two New Nominees for Election to Board of Directors
Apr 9 INCY Seeking Alpha Catalyst Watch
Apr 9 INCY Lilly's (LLY) JAK Inhibitor Olumiant Fails COVID-19 Study
Apr 9 BIIB Provention Bio downgraded on FDA feedback, Citi sizes up Zuranolone success on Sage, and more in today’s analyst action
Apr 9 INCY Provention Bio downgraded on FDA feedback, Citi sizes up Zuranolone success on Sage, and more in today’s analyst action
Apr 8 BIIB Biotech Stocks Could Use A Win — Will The First Quarter Offer That?